Swiss National Bank Has $52.93 Million Position in Waters Corporation (WAT)
Swiss National Bank increased its position in shares of Waters Corporation (NYSE:WAT) by 0.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 294,859 shares of the medical instruments supplier’s stock after purchasing an additional 2,600 shares during the quarter. Swiss National Bank owned approximately 369,404.91% of Waters Corporation worth $52,933,000 as of its most recent SEC filing.
A number of other institutional investors have also recently added to or reduced their stakes in WAT. Oppenheimer Asset Management Inc. boosted its holdings in Waters Corporation by 0.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 2 shares during the last quarter. ETF Managers Group LLC purchased a new position in Waters Corporation during the second quarter worth about $106,000. Intellectus Partners LLC boosted its holdings in Waters Corporation by 4.9% during the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares during the last quarter. First Manhattan Co. purchased a new position in Waters Corporation during the second quarter worth about $130,000. Finally, Edmond DE Rothschild Holding S.A. purchased a new position in Waters Corporation during the second quarter worth about $160,000. Institutional investors and hedge funds own 91.82% of the company’s stock.
Shares of Waters Corporation (NYSE:WAT) opened at $194.64 on Tuesday. Waters Corporation has a 12-month low of $133.35 and a 12-month high of $199.78. The company has a debt-to-equity ratio of 0.66, a current ratio of 6.16 and a quick ratio of 5.71. The stock has a market cap of $15,366.58, a P/E ratio of 26.83, a PEG ratio of 2.80 and a beta of 0.83.
Waters Corporation (NYSE:WAT) last posted its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.03. Waters Corporation had a net margin of 24.34% and a return on equity of 23.61%. The company had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same quarter in the previous year, the firm posted $1.57 earnings per share. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. sell-side analysts expect that Waters Corporation will post 7.42 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Swiss National Bank Has $52.93 Million Position in Waters Corporation (WAT)” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/11/14/swiss-national-bank-has-52-93-million-position-in-waters-corporation-wat.html.
Several research analysts recently weighed in on WAT shares. Deutsche Bank AG boosted their price target on shares of Waters Corporation from $199.00 to $200.00 and gave the stock a “hold” rating in a report on Wednesday, October 25th. Morgan Stanley reaffirmed an “underweight” rating and issued a $183.00 price objective (up previously from $174.00) on shares of Waters Corporation in a research report on Wednesday, July 26th. Zacks Investment Research raised shares of Waters Corporation from a “hold” rating to a “buy” rating and set a $211.00 price objective on the stock in a research report on Monday, October 23rd. Barclays PLC lifted their price objective on shares of Waters Corporation from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research report on Wednesday, October 25th. Finally, Bank of America Corporation reaffirmed a “neutral” rating and issued a $192.00 price objective (up previously from $180.00) on shares of Waters Corporation in a research report on Friday, July 21st. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $193.62.
In other news, SVP Rohit Khanna sold 26,913 shares of the business’s stock in a transaction that occurred on Friday, October 27th. The shares were sold at an average price of $197.93, for a total value of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at $2,707,088.61. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the completion of the sale, the senior vice president now directly owns 18,129 shares in the company, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. In the last three months, insiders sold 57,313 shares of company stock worth $11,120,642. Insiders own 5.07% of the company’s stock.
About Waters Corporation
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.